Don C Des Jarlais

Summary

Publications

  1. pmc Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia
    Anneli Uuskula
    Department of Public Health, University of Tartu, Tartu, Estonia
    BMC Public Health 11:517. 2011
  2. pmc Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23d Street, 8th Floor, New York, NY 10010, USA
    BMC Public Health 8:94. 2008
  3. pmc Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients
    Gianluca Quaglio
    Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
    BMC Public Health 6:216. 2006
  4. pmc HIV risk behaviors among female IDUs in developing and transitional countries
    Charles M Cleland
    Center for Drug Use and HIV Research, National Development and Research Institutes Inc, 71 West 23rd Street, New York, NY 10010, USA
    BMC Public Health 7:271. 2007
  5. pmc The HCV Synthesis Project: scope, methodology, and preliminary results
    Rebecca K Stern
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    BMC Med Res Methodol 8:62. 2008
  6. pmc Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services
    Shiela M Strauss
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    BMC Health Serv Res 7:39. 2007
  7. pmc Data and public health decision making on HIV prevention in injection drug users
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY, USA
    J Urban Health 85:303-5. 2008
  8. ncbi HIV prevention for injecting drug users: the first 25 years and counting
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York 10038, USA
    Psychosom Med 70:606-11. 2008
  9. doi Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:S109-14. 2007
  10. ncbi HIV prevention research: cumulative knowledge or accumulating studies? An introduction to the HIV/AIDS prevention research synthesis project supplement
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York New York 10003, USA
    J Acquir Immune Defic Syndr 30:S1-7. 2002

Collaborators

Detail Information

Publications111 found, 100 shown here

  1. pmc Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia
    Anneli Uuskula
    Department of Public Health, University of Tartu, Tartu, Estonia
    BMC Public Health 11:517. 2011
    ..We assessed the effects of expanded syringe exchange programs (SEP) in the capital city, Tallinn, which has an estimated 10,000 IDUs...
  2. pmc Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23d Street, 8th Floor, New York, NY 10010, USA
    BMC Public Health 8:94. 2008
    ..Prevalence rates for long-term injection drug users in some localities surpass 60% for HIV and 80% for HCV. We describe methods for developing grounded hypotheses about how some injectors avoid infection with either virus...
  3. pmc Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients
    Gianluca Quaglio
    Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
    BMC Public Health 6:216. 2006
    ....
  4. pmc HIV risk behaviors among female IDUs in developing and transitional countries
    Charles M Cleland
    Center for Drug Use and HIV Research, National Development and Research Institutes Inc, 71 West 23rd Street, New York, NY 10010, USA
    BMC Public Health 7:271. 2007
    ..Most data on gender differences come from industrialized countries, so data are needed in developing countries to determine how well gender differences generalize to these understudied regions...
  5. pmc The HCV Synthesis Project: scope, methodology, and preliminary results
    Rebecca K Stern
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    BMC Med Res Methodol 8:62. 2008
    ..The hepatitis C virus (HCV) is hyper-endemic in injecting drug users. There is also excess HCV among non-injection drug users who smoke, snort, or sniff heroin, cocaine, crack, or methamphetamine...
  6. pmc Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services
    Shiela M Strauss
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    BMC Health Serv Res 7:39. 2007
    ..Little is known, however, about the level of HCV knowledge among drug treatment program patients, and the extent to which they utilize their programs' HCV education services...
  7. pmc Data and public health decision making on HIV prevention in injection drug users
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY, USA
    J Urban Health 85:303-5. 2008
  8. ncbi HIV prevention for injecting drug users: the first 25 years and counting
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York 10038, USA
    Psychosom Med 70:606-11. 2008
    ..Programs that provide these services need to be implemented on a public health scale for IDU populations at risk for HIV infection...
  9. doi Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:S109-14. 2007
    ..To assess an HIV prevention programme for injecting drug users (IDU) in the crossborder area between China and Vietnam...
  10. ncbi HIV prevention research: cumulative knowledge or accumulating studies? An introduction to the HIV/AIDS prevention research synthesis project supplement
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York New York 10003, USA
    J Acquir Immune Defic Syndr 30:S1-7. 2002
  11. ncbi Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    J Am Pharm Assoc (Wash) 42:S73-6. 2002
    ..To assess preliminary results of the Expanded Syringe Access Demonstration Program (ESAP) in New York City...
  12. ncbi Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Epidemiol 157:467-71. 2003
    ..0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence...
  13. ncbi Herpes simplex virus-2 and HIV among noninjecting drug users in New York city
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Sex Transm Dis 34:923-7. 2007
    ..To examine the relationship between herpes simplex virus 2 (HSV-2) seroprevalence and human immunodeficiency virus (HIV) seroprevalence among noninjecting heroin and cocaine users in New York City...
  14. pmc HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services
    Don C Des Jarlais
    Beth Israel Medical Center, 1st Ave and 16th St, New York, NY 10003, USA
    Am J Public Health 95:1439-44. 2005
    ..Syringe exchange increased greatly during this period, from 250,000 to 3,000,000 syringes exchanged annually...
  15. ncbi Reducing syringe sharing among injecting drug users in Winnipeg: 81% success or 19% failure?
    Don Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, USA
    Addiction 102:1636. 2007
  16. ncbi "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center and dagger National Development and Research Institutes, Inc, New York, NY, USA
    J Acquir Immune Defic Syndr 35:158-66. 2004
    ..To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world...
  17. ncbi Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    AIDS 19:S20-5. 2005
    ..The 1990-2001 time period included a very large expansion of syringe exchange in New York City, from 250,000 to 3,000,000 syringes exchanged annually...
  18. pmc Social factors associated with AIDS and SARS
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Emerg Infect Dis 11:1767-9. 2005
    ..We conducted a survey of 928 New York City area residents to assess knowledge and worry about AIDS and SARS. Specific sociodemographic groups of persons were more likely to be less informed and more worried about contracting the diseases...
  19. pmc Stigmatization of newly emerging infectious diseases: AIDS and SARS
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water St, 24th Floor, New York, NY 10038, USA
    Am J Public Health 96:561-7. 2006
    ..We assessed relationships between sociodemographic characteristics and mental health status and knowledge of, being worried about, and stigmatization of 2 emerging infectious diseases: AIDS and SARS...
  20. pmc Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    BMC Public Health 6:54. 2006
    ..We report on the development and implementation of the methodology underlying the survey component of the WHO Drug Injection Study Phase II--a multi-site study of risk behavior and HIV seroprevalence among Injecting Drug Users (IDUs)...
  21. ncbi Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:231-5. 2007
    ..As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users...
  22. pmc Public funding of US syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    J Urban Health 81:118-21. 2004
    ..In the absence of federal funding, state and local government support is associated with better syringe exchange performance...
  23. ncbi The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    Addiction 102:778-85. 2007
    ..To characterize heroin and cocaine users in New York City who have changed from injection to non-injection drug administration and to identify factors associated with long-term non-injection use...
  24. pmc Evidence-based public health: moving beyond randomized trials
    Cesar G Victora
    Post Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
    Am J Public Health 94:400-5. 2004
    ..There is an urgent need to develop evaluation standards and protocols for use in circumstances where RCTs are not appropriate...
  25. pmc Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA
    Am J Public Health 94:361-6. 2004
    ..These guidelines emphasize the reporting of theories used and descriptions of intervention and comparison conditions, research design, and methods of adjusting for possible biases in evaluation studies that use nonrandomized designs...
  26. doi Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, NewYork, NY 10038, USA
    Drug Alcohol Depend 101:88-91. 2009
    ..We examined the relationships between HCV and HIV and between HSV-2 and HIV among injecting drug users in New York City relative to the large-scale implementation of syringe exchange in the mid-1990s...
  27. doi Doing harm reduction better: syringe exchange in the United States
    Don C Des Jarlais
    Beth Israel Medical Center, 160Water Street 24th Floor, NewYork, NY 10038, USA
    Addiction 104:1441-6. 2009
    ..To trace the growth of syringe exchange programs (SEPs) in the United States since 1994-95 and assess the current state of SEPs...
  28. pmc Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    BMC Public Health 5:89. 2005
    ..To assess patterns of injecting drug use and HIV prevalence among injecting drug users (IDUs) in an international border area along a major heroin trans-shipment route...
  29. doi Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    Sex Transm Dis 37:637-43. 2010
    ..To examine prevalence of and associations between herpes simplex virus type 2 (HSV-2) infection and HIV infection among never-injecting heroin and cocaine drug users (NIDUs) in New York City...
  30. doi HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    Subst Use Misuse 46:131-9. 2011
    ....
  31. pmc Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997
    C Des Jarlais
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    Am J Public Health 90:1112-6. 2000
    ..This study assessed trends in HIV risk behaviors among injection drug users in New York City from 1990 to 1997...
  32. ncbi HIV surveillance among injecting drug users
    D C Des Jarlais
    Edmond de Rothschild Foundation, Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    AIDS 15:S13-22. 2001
    ..HIV incidence is an ultimate objective for surveillance research, but there are no currently available cost-efficient methods for studying HIV incidence, so estimation from indirect measurements is usually required...
  33. pmc Diffusion of the D.A.R.E and syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    Am J Public Health 96:1354-8. 2006
    ..The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations...
  34. doi HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street 24th Floor, New York, NY 10038 USA
    Drug Alcohol Depend 109:154-60. 2010
    ..To identify potential behavioral mechanisms through which combined programs are effective...
  35. doi Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water St 24th Fl, New York, NY 10038, USA
    Am J Public Health 99:S445-51. 2009
    ..We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City...
  36. pmc Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996
    D C Des Jarlais
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Public Health 88:1801-6. 1998
    ..This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City...
  37. pmc Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done
    D C Des Jarlais
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Public Health Rep 113:182-8. 1998
    ..This chapter reviews the history of research on implementation of programs for prevention of HIV infection among IDUs...
  38. doi HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Curr Opin HIV AIDS 4:308-13. 2009
    ..To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs)...
  39. doi HIV prevention and psychoactive drug use: a research agenda
    D C Des Jarlais
    Beth Israel Medical Center CDI, 160 Water Street, New York, NY 10038, USA
    J Epidemiol Community Health 63:191-6. 2009
    ....
  40. pmc Research, politics, and needle exchange
    D C Des Jarlais
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    Am J Public Health 90:1392-4. 2000
    ..This may be considered progress to an important but modest degree. Whether current and future research will be used to improve HIV prevention efforts remains to be seen...
  41. doi Can intranasal drug use reduce HCV infection among injecting drug users?
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    Drug Alcohol Depend 119:201-6. 2011
    ..Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition...
  42. ncbi Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood
    P L Flom
    National Development and Research Institutes, New York, New York 10048, USA
    Sex Transm Dis 28:598-607. 2001
    ..Sex risks and drug use are related. This relation in youth is described...
  43. ncbi Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996
    S R Friedman
    National Development and Research Institutes, Inc, New York, New York 10048, USA
    J Acquir Immune Defic Syndr 22:83-91. 1999
    ..To measure differences and similarities in the prevalence of HIV infection and of related risk and protective behaviors among New York City black, white, and Hispanic drug injectors during a period of decreasing HIV prevalence...
  44. ncbi Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood
    S R Friedman
    National Development Research Institutes, Inc, New York, NY, USA
    AIDS 15:2057-60. 2001
    ..Having ever had anal sex was associated with having ever been infected with hepatitis B...
  45. ncbi Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation
    S R Friedman
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10048, USA
    Am J Epidemiol 152:913-22. 2000
    ..Thus, in situations of declining prevalence, prevention programs should be maintained or strengthened...
  46. ncbi Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus
    A Neaigus
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10048, USA
    J Infect Dis 184:359-63. 2001
    ..HIV-infected NIUs, particularly never IDUs, and, possibly, HCV-infected NIUs, are a potential sexual transmission bridge...
  47. ncbi Drug scene roles and HIV risk
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    Addiction 93:1403-16. 1998
    ..This paper aims to measure "role behaviors" of drug injectors; describe which drug injectors are more likely to engage in such role behaviors; and to determine whether roles are related to elements of HIV risk...
  48. ncbi Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors
    A Neaigus
    National Development and Research Institutes, Inc, New York City, NY, USA
    Addiction 96:847-60. 2001
    ..To compare potential risk factors for the transition to injecting among non-injecting heroin users (NIUs) with different injecting histories...
  49. ncbi Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighbourhood and do not use "hard drugs"
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    AIDS Care 13:285-96. 2001
    ..Programmes to increase condom use among young adults should focus on strengthening norms that promote safer sex to protect oneself and others. In addition, assistance should be provided to youth who are problem drinkers...
  50. ncbi Doing a shotgun: a drug use practice and its relationship to sexual behaviors and infection risk
    D C Perlman
    Beth Israel Medical Center, New York, NY 10003, USA
    Soc Sci Med 48:1441-8. 1999
    ..These data support the need to develop and evaluate comprehensive risk reduction interventions, which take into consideration the relationships between interpersonal and sexual behaviors and specific forms of drug use...
  51. ncbi Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program
    N Salomon
    Department of Medicine, Beth Israel Medical Center, New York, New York 10003, USA
    Int J Tuberc Lung Dis 4:47-54. 2000
    ..To evaluate the prevalence and predictors of tuberculin skin test (TST) reactions > or =10 mm among active injection drug users (IDUs) at a syringe exchange program in New York City...
  52. ncbi Organizational issues in conducting tuberculosis screening at a syringe exchange program
    D Paone
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    J Subst Abuse Treat 15:229-34. 1998
    ....
  53. ncbi Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment
    S Deren
    National Development and Research Institutes, Inc, Two World Trade Center, 16th Floor, New York, NY 10048, USA
    J Subst Abuse Treat 20:185-9. 2001
    ..Efforts to identify concerns of new admissions early in treatment, and programs to continue drug treatment services to incarcerated clients, are indicated...
  54. ncbi Continued risky injection subsequent to syringe exchange use among injection drug users in New York City
    D Paone
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    AIDS Educ Prev 9:505-10. 1997
    ..We present other predictors of continued risk and discuss the implications for interventions and make recommendations for syringe exchange programs...
  55. pmc Drug injection rates and needle-exchange use in New York City, 1991-1996
    M Marmor
    Department of Environmental Medicine, Center for AIDS Research, New York University School of Medicine, New York City, USA
    J Urban Health 77:359-68. 2000
    ..The ability of a syringe-exchange program to attract a disproportionate share of drug users with accelerating rates of drug injection underscores the importance of these programs to HIV prevention efforts...
  56. pmc Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence
    S R Friedman
    National Development and Research Institutes, Inc, Two World Trade Center, 16th Fl, New York, NY 10048, USA
    Am J Public Health 91:791-3. 2001
    ..This study sought to assess relations of laws prohibiting over-the-counter syringe sales (anti-OTC laws) to population prevalence of injection drug users and HIV prevalence or incidence among 96 US metropolitan areas...
  57. pmc Alcohol and HIV sexual risk behaviors among injection drug users
    Kamyar Arasteh
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Drug Alcohol Depend 95:54-61. 2008
    ..These observations indicate both global and event-specific associations of alcohol and HIV sexual-risk behaviors...
  58. ncbi Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users
    V Anna Gyarmathy
    National Development and Research Institutes, Inc, New York City, New York 10010, USA
    J Acquir Immune Defic Syndr 30:448-56. 2002
    ..To examine lifetime correlates of HIV and hepatitis B and C (HBV and HCV) infections among noninjecting heroin users (NIUs)...
  59. ncbi Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Infect Dis 195:1052-61. 2007
    ..Many heroin users do not inject drugs but may still be at risk of infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV), via sexual or other noninjection-related activity...
  60. ncbi HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs
    Naomi Braine
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    AIDS Educ Prev 17:515-24. 2005
    ..SEPs may need to develop new approaches to outreach and education to address the needs of amphetamine injectors and other populations at persistent risk...
  61. pmc The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units
    Shiela M Strauss
    National Development and Research Institutes Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 81:38-47. 2004
    ..Drug treatment programs need to educate patients about the proactive steps these individuals can take to deal with HCV, provide critically needed HCV services, and encourage patients to make full use of these services...
  62. ncbi Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users
    Benny J Kottiri
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, New York, USA
    J Acquir Immune Defic Syndr 30:95-104. 2002
    ..In Bushwick, racially/ethnically discordant risk partnerships involving black IDUs may function as potential bridges of transmission between groups...
  63. ncbi Consistent condom use among drug-using youth in a high HIV-risk neighbourhood
    S R Friedman
    National Development Research Institutes, Inc, New York, NY 10010, USA
    AIDS Care 14:493-507. 2002
    ..These changes should include changes in gender roles and power relations...
  64. pmc Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug
    Barbara Tempalski
    National Development and Research Institutes, Inc, New York, NY, USA
    Int J Drug Policy 19:S47-58. 2008
    ..Notably, we know little about variations in syringe coverage within the U.S. and elsewhere, or about the social and political factors that might determine this coverage...
  65. ncbi Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    AIDS Behav 11:78-84. 2007
    ..To assess variation in injection risk behavior among unstably housed/homeless injecting drug users (IDUs) across programs in a national sample of US syringe exchange programs...
  66. pmc Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, NY, United States
    Int J Drug Policy 18:107-17. 2007
    ..Finally, both researchers and policy makers should help develop ways to enable and support both micro-social and formally organized action by users...
  67. pmc Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes Inc, 71 West 23rd Street, New York City, NY 10010, USA
    Drug Alcohol Depend 89:234-43. 2007
    ..Early interventions, targeting injecting and sexual risks and including HBV vaccination, are needed among new IDUs to prevent HBV, HCV and, potentially, HIV epidemics...
  68. ncbi Long-term effects of syringe exchange on risk behavior and HIV prevention
    Naomi Braine
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    AIDS Educ Prev 16:264-75. 2004
    ..This study confirms previous findings that SEPs can play a significant role in the prevention of HIV in marginal and impoverished communities in the United States...
  69. ncbi Hazardous drinking and HIV sexual risk behaviors among injection drug users in developing and transitional countries
    Kamyar Arasteh
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    AIDS Behav 14:862-9. 2010
    ..These findings in the context of the high prevalence of drinking in many sites point to the importance of addressing alcohol use in HIV education and prevention policy for IDUs...
  70. ncbi Community attitudes toward HIV prevention for injection drug users: findings from a cross-border project in southern China and northern Vietnam
    Theodore M Hammett
    Abt Associates, Inc, 55 Wheeler Street, Cambridge, MA 02138, USA
    J Urban Health 82:iv34-42. 2005
    ..Additional education, including dissemination of countervailing project data, is necessary to address these deficits and further increase community support for the interventions...
  71. ncbi Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 41:493-503. 2006
    ..To determine the incidence/predictors of transitions to injecting among noninjecting heroin users (NIUs)...
  72. ncbi Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S
    Shiela M Strauss
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    Drug Alcohol Depend 83:15-24. 2006
    ..Similar analyses in other countries can inform their policy makers about the capacity of their drug treatment programs to provide support to their HCV infected patients...
  73. pmc Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program
    D C Perlman
    Beth Israel Medical Center, First Avenue at 16th Street, New York City, NY 10003, USA
    J Urban Health 78:550-67. 2001
    ..Monetary incentives for those referred for screening CXRs would be justified on a cost basis if they had even a modest beneficial impact on adherence...
  74. ncbi Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program
    Enrique R Pouget
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 39:471-7. 2005
    ....
  75. ncbi Provision of hepatitis C education in a nationwide sample of drug treatment programs
    Janetta Astone
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Drug Educ 33:107-17. 2003
    ..Our findings indicate that there is a need to increase HCV educational services in drug treatment programs...
  76. ncbi Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units
    Shiela M Strauss
    National Development and Research Institutes, Inc, New York, New York 10010, USA
    AIDS Patient Care STDS 19:78-88. 2005
    ..Policy makers and individual treatment units need to develop strategies that capitalize on existing infrastructures while maintaining the distinction between HIV and HCV primary and secondary prevention efforts...
  77. ncbi Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services
    Janetta M Astone
    National Development and Research Institutes, Inc, 71 West 23rd St, 8th Floor, New York, NY 10010, USA
    Am J Drug Alcohol Abuse 30:783-97. 2004
    ..Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication...
  78. ncbi Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs
    Theresa E Perlis
    National Development and Research Institutes, Inc, New York, NY 10003, USA
    Addiction 99:885-96. 2004
    ..A-CASI has been found to increase reporting of sensitive items among a variety of population subgroups...
  79. pmc Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas
    Barbara Tempalski
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 97:437-47. 2007
    ..Need was not a predictor...
  80. pmc The differential effects of face-to-face and computer interview modes
    Jessica Clark Newman
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    Am J Public Health 92:294-7. 2002
    ..This study assessed the differential effects of face-to-face interviewing and audio-computer assisted self-interviewing (audio-CASI) on categories of questions...
  81. doi Learning from HIV epidemics among injecting drug users
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 160 Water Street, Room 2462, 24th Floor, New York, NY 10038, USA
    Int J Drug Policy 21:97-9. 2010
    ..Nevertheless, international harm reduction for people who use drugs has moved beyond HIV/AIDS to a variety of other health and social problems, while retaining firm bases in science and human rights...
  82. pmc Syringe exchange in the United States, 1996: a national profile
    D Paone
    Beth Israel Medical Center, New York, NY 10003, USA
    Am J Public Health 89:43-6. 1999
    ..This paper provides 1996 information on the status of US syringe exchange programs and compares these findings with data from our 1994 survey...
  83. pmc Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999
    Carey B Maslow
    National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA
    Am J Public Health 92:382-4. 2002
    ..This study examined HIV prevalence and risk behaviors among male injection drug users (IDUs) who have sex with men and among other male IDUs...
  84. pmc Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
    Russell Rockwell
    National Development and Research Institutes, Inc, New York, New York, USA
    J Urban Health 79:136-46. 2002
    ..Enhancing access to services for IDUs in the boroughs outside Manhattan may be needed to continue the positive trends in all areas of New York City...
  85. pmc HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women
    Samuel R Friedman
    National Development and Research Institutes Inc, New York, NY 10010, USA
    Am J Public Health 93:902-6. 2003
  86. ncbi Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs
    Zdravko P Vassilev
    National Development and Research Institutes Inc, 71 W 23 St 8th floor, New York, NY 10010, USA
    J Behav Health Serv Res 31:208-16. 2004
    ....
  87. ncbi Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institutes, New York, New York 10010, USA
    Epidemiology 15:543-9. 2004
    ....
  88. ncbi Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs
    Corrine E Munoz-Plaza
    STOP HEP C Project, New York, NY, USA
    J Psychoactive Drugs 38:233-41. 2006
    ..While programs need more funding and resources to overcome these barriers, these findings may prove helpful to other drug treatment programs that would like to offer HCV services to at least some of their clients...
  89. ncbi Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    AIDS 20:93-9. 2006
    ..To understand associations of punitive policies to the population prevalence of injection drug users and to HIV seroprevalence among injectors...
  90. ncbi Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    AIDS Educ Prev 19:111-23. 2007
    ....
  91. pmc Updating the infection risk reduction hierarchy: preventing transition into injection
    David Vlahov
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    J Urban Health 81:14-9. 2004
    ....
  92. ncbi HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institute, New York, NY 10010, USA
    AIDS 19:S199-207. 2005
    ....
  93. doi Syringe exchange, injecting and intranasal drug use
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    Addiction 105:155-8. 2010
    ..The belief that implementation of syringe exchange will lead to increased drug injecting has been a persistent argument against syringe exchange...
  94. doi Mortality risk among recent-onset injection drug users in five U.S. cities
    David Vlahov
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, New York 10029, USA
    Subst Use Misuse 43:413-28. 2008
    ....
  95. ncbi Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
    M Latka
    Center for Urban Epidemiologic Studies, Room 556, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    J Subst Abuse 13:73-88. 2001
    ..To measure prevalence, incidence, and correlates of chlamydia and gonorrhea among injection drug users (IDUs)...
  96. pmc Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review
    Jonathan P Feelemyer
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA Electronic address
    Drug Alcohol Depend 134:251-8. 2014
    ..However, there is little systematic understanding of WHOQOL-BREF and ASI domain changes among OST participants in low and middle-income countries (LMIC)...
  97. pmc Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
    M Zeremski
    Division of Gastroenterology and Hepatology, Department of Medicine, Center for the Study of Hepatitis C, Weill Cornell Medical College, New York, NY 10065 4896, USA
    J Viral Hepat 16:10-20. 2009
    ..The responses are broad and are associated with risk factors for HCV exposure, suggesting that they reflect true exposure to HCV in seronegative persons...
  98. ncbi HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand
    Kachit Choopanya
    Bangkok Metropolitan Administration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 33:88-95. 2003
    ..To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand...
  99. ncbi Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam
    Theodore M Hammett
    Abt Associates, Cambridge, MA 02138 1168, USA
    J Acquir Immune Defic Syndr 38:228-35. 2005
    ..Their greater likelihood of engaging in risk reduction measures may reflect some combination of a belief that risk reduction can slow disease progression and an altruistic desire to avoid infecting others...
  100. ncbi HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, New York, NY 10010, United States
    Int J Drug Policy 18:341-51. 2007
    ..This will permit synthesis of a greater number of studies and may lead to the identification of factors that impede HCV transmission...
  101. ncbi Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand
    Suphak Vanichseni
    Bangkok Metropolitan Administration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 37:1170-9. 2004
    ..This study assessed whether long-term participation in interventions to reduce sexual risk behavior was associated with reduced sexual risk behavior...